InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Ingram Robert Alexander. Officer active across 4 companies, notably Biocryst Pharmaceuticals INC. Aggregated, 18 disclosures have been published. Activity tracked since 28 May 2021. The latest transaction was filed on 28 February 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Ingram Robert Alexander
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
2,259 shares@ US$8.8510.0% of flowCommon StockSEC:0001127602-23-008391:0
9,375 shares@ US$1.508.7% of flowCommon StockSEC:0001415889-22-012795:0
1,497 shares@ US$13.3610.3% of flowCommon StockSEC:0001127602-22-026823:0
6,584 shares@ US$2.6211.3% of flowCommon StockSEC:0001415889-22-009771:0
1,438 shares@ US$13.9010.6% of flowCommon StockSEC:0001127602-22-022009:0
8,498 shares@ US$2.030.012% mcap13.4% of flowCommon StockSEC:0001415889-22-006739:0
12,866 shares0Common StockSEC:0001127602-22-017165:0
2,078 shares@ US$9.310.0011% mcap13.8% of flowCommon StockSEC:0001127602-22-016390:0
5,795 shares@ US$3.0214.7% of flowCommon StockSEC:0001415889-22-003184:0
1,128 shares@ US$16.6111.9% of flowCommon StockSEC:0001127602-22-007725:0
3,296 shares@ US$5.3114.4% of flowCommon StockSEC:0001415889-21-006070:0
1,554 shares@ US$12.0611.8% of flowCommon StockSEC:0001127602-21-030043:0
1,869 shares@ US$9.9014.6% of flowCommon StockSEC:0001415889-21-004540:0
1,177 shares@ US$15.9211.3% of flowCommon StockSEC:0001127602-21-024776:0
1,255 shares@ US$12.9512.7% of flowCommon StockSEC:0001104659-21-084242:0
1,188 shares@ US$15.7710.9% of flowCommon StockSEC:0001127602-21-018501:0
1,093 sharesCOMMON STOCKSEC:0000895419-16-000116:0
239 sharesCommon Stock, no par valueSEC:0000885590-16-000081:0
18 of 18 declarations
About Ingram Robert Alexander
INGRAM ROBERT ALEXANDER is a declarant linked to Biocryst Pharmaceuticals INC, Black Diamond Therapeutics, Inc., CREE INC and Valeant Pharmaceuticals International, Inc., with the role of Director for some of these companies. He has 18 filings in total, and across the recent filings held, the period runs from 2016-01-04 to 2023-03-02, with attribution entries and no buy or sell amounts indicated.
